Related Experiment Video

Updated: Aug 1, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.5K

Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease

Cortney N Steele1, Kristen L Nowak1

  • 1Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO.

Advances in Kidney Disease and Health
|April 23, 2023
PubMed

Insights

Lifestyle modifications are crucial for managing autosomal dominant polycystic kidney disease (ADPKD). Strategies like diet, hydration, and weight management can significantly impact ADPKD progression and treatment.

Area of Science:

  • Nephrology
  • Genetics
  • Internal Medicine

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a progressive genetic disorder leading to kidney cyst development and enlargement.
  • Nonpharmacological interventions are vital for ADPKD management, complementing or replacing drug therapies.

Purpose of the Study:

  • To review current evidence on nonpharmacological strategies for managing autosomal dominant polycystic kidney disease.
  • To highlight the clinical impact and utility of lifestyle modifications in ADPKD treatment.

Main Methods:

  • Review of existing literature, including cell culture, animal, epidemiological, and clinical studies.
  • Analysis of evidence supporting various nonpharmacological interventions for ADPKD.

Main Results:

  • Nonpharmacological strategies evaluated include blood pressure management, calorie restriction, weight loss, hydration, caffeine limitation, sodium, protein, and phosphorus restriction, and acid load reduction.
  • Evidence suggests these lifestyle modifications are beneficial in ADPKD management.

Conclusions:

  • Lifestyle modifications should be a cornerstone of autosomal dominant polycystic kidney disease treatment.
  • Further research and clinical trials are needed to solidify the evidence base for nonpharmacological ADPKD interventions.
Keywords:
DietHydrationObesityPolycystic kidney diseaseSodium

More Related Videos

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

9.8K
Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay08:13

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay

Published on: February 20, 2015

13.3K

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
57
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
11
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
32
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
49
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
120
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
20